PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,399,000 | – | 277,374 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,248,306 | $27,407,000 | 2.86% |
| Orbimed Advisors | 13,822,463 | $168,496,000 | 2.83% |
| Omega Fund Management, LLC | 272,807 | $3,326,000 | 1.38% |
| RA Capital Management | 3,240,534 | $39,502,000 | 1.25% |
| Boxer Capital, LLC | 1,123,105 | $13,691,000 | 0.93% |
| BVF INC/IL | 431,483 | $5,260,000 | 0.49% |
| DAFNA Capital Management LLC | 75,000 | $914,000 | 0.38% |
| QVT Financial LP | 133,690 | $1,630,000 | 0.38% |
| Woodline Partners LP | 251,532 | $3,066,000 | 0.22% |
| Artal Group S.A. | 200,000 | $2,438,000 | 0.10% |